Publications of the last 5 years
Here is a list of publications of the team over the last 5 years, for all the data you can view the output page.
Refereed articles (rank A)
-
Michel, M. ; Caré, F. ; Bourg, S. ; Bostyn, S. ; Lafite, P. ; Routier, S. ; Buron, F.
Access to mono-, di- and tri-(het)arylated pyrazolo[5,1-b]oxazoles using cyclization, C−H activation and Suzuki–Miyaura palladium-catalyzed reactions
Eur. J. Org. Chem. 2024, 27, e202301040.
Impact Factor: 2.8 - Quartile : 1 -
Sangare, D. ; Caré, F. ; Buron, F. ; Lafite, P. ; Bostyn, S.
Numerical modeling and evaluation of solid-liquid extraction with pressurized hot water extraction applied to Robinia Pseudoacacia wood
Chemical Engineering and Processing - Process Intensification 2024, 195, 109605.
Impact Factor: 4.3 -
Caré, F. ; Sangare, D. ; Bostyn, S. ; Atwi-Ghaddar, S. ; Lafite, P. ; Buron, F.
Computational Fluid Dynamics (CFD) modeling of static maceration in view to optimize continuous flow extractions of robinetin and dihydrorobinetin from Robinia pseudoacacia wood
Food and Bioproducts Processing 2023, 141, 185-198.
Impact Factor: 4.6 - Quartile : 1 -
Colliec-Jouault, S. ; Esposito, F. ; Ledru, H. ; Sinquin, C. ; Marchand, L. ; Fillaudeau, A. ; Routier, S. ; Buron, F. ; Lopin-Bon, C. ; Cuenot, S. ; Bedini, E. ; Zykwinska, A.
Glycosaminoglycan mimetics obtained by microwave-assisted sulfation of marine bacterium sourced infernan exopolysaccharide
Biomacromolecules 2023, 24, 462–470.
Impact Factor: 6.2 - Quartile : 1 -
Ejjoummany, A. ; Elie, J. ; El Akkaoui, A. ; Akssira, M. ; Routier, S. ; Buron, F.
Access and modulation of substituted pyrrolo[3,4-c]pyrazole-4,6-(2H,5H)-diones
Molecules 2023, 28, 5811.
Impact Factor: 4.6 - Quartile : 2 -
Kamzol, D. ; Neuville, M. ; Cocaud, C. ; Tiger, K. ; Taffoureau, B. ; Lewinski, K. ; Jaszczyk, J. ; Martin, O. R. ; Bas, S. ; Routier, S. ; Gillaizeau, I. ; Buron, F. ; Nicolas, C.
Stereoselective synthesis of iminosugar-C-glycosides through addition of organometallic reagents to N-tert-butanesulfinyl glycosylamines: A comprehensive study
Eur. J. Org. Chem. 2023, 26, e202300762.
Impact Factor: 2.8 - Quartile : 1 -
Avula, S. ; Peng, X. ; Lang, X. ; Tortorella, M. ; Josselin, B. ; Bach, S. ; Bourg, S. ; Bonnet, P. ; Buron, F. ; Ruchaud, S. ; Routier, S. ; Néagoie, C.
Design and biological evaluation of substituted 5,7-dihydro-6H-indolo[2,3-c]quinolin-6-one as novel selective Haspin inhibitors
J. Enzym. Inhib. Med. Chem. 2022, 37, 1632-1650.
Impact Factor: 5.6 -
Berabez, R. ; Routier, S. ; Bénédetti, H. ; Plé, K. ; Vallée, B.
LIM Kinases, promising but reluctant therapeutic targets: chemistry and preclinical validation in vivo
Cells 2022, 11, 2090.
Impact Factor: 6 -
Chairat, A. ; Laurent, M. ; Routier, S. ; Buron, F. ; Bostyn, S.
Modeling temperature and species concentration profiles on a continuous-flow reactor applied to aldol condensation
ACS Omega 2022, 7, 19166–19175.
Impact Factor: 4.1 -
Garnier, S. ; Brugemann, K. ; Zak, A. ; Vercouillie, J. ; Potier-Cartereaux, M. ; Marchivie, M. ; Routier, S. ; Buron, F.
A facile one-pot synthesis of new poly functionalized pyrrolotriazoles via a regioselective multicomponent cyclisation and Suzuki–Miyaura coupling reactions
Catalysts 2022, 12, 828.
Impact Factor: 3.9 -
Lapaillerie, D. ; Charlier, C. ; Guyonnet-Dupérat, V. ; Murigneux, E. ; Fernandes, H. S. ; Martins, F. G. ; Magalhães, R. P. ; Vieira, T. F. ; Richetta, C. ; Subra, F. ; Lebourgeois, S. ; Charpentier, C. ; Descamps, D. ; Visseaux, B. ; Weigel, P. ; Favereaux, A. ; Beauvineau, C. ; Buron, F. ; Teulade-Fichou, M.-P. ; Routier, S. ; Gallois-Montbrun S. ; Meertens, L. ; Delelis, O. ; Sousa, S. F. ; Parissi, V.
Selection of bis-indolyl pyridines and triphenylamines as new inhibitors of SARS-CoV-2 cellular entry by modulating the spike protein/ACE2 interfaces
Antimicrob. Agents Chemother. 2022, 66, 1-15.
Impact Factor: 4.9 -
Pescheteau, C. ; Place, M. ; Sava, A. ; Nunes, L. ; Profire, L. ; Routier, S. ; Buron, F.
Synthesis of novel series of 3,5-disubstituted imidazo[1,2-d] [1,2,4]thiadiazoles involving SNAr and Suzuki–Miyaura cross-coupling reactions
RSC Advances 2022, 12, 6303-6313.
Impact Factor: 3.9 -
Soklou, K. E. ; Marzag, H. ; Vallée, B. ; Routier, S. ; Plé, K.
Synthesis of heterospirocycles through gold-(I) catalysis: useful building blocks for medicinal chemistry
Adv. Synth. Catal. 2022, 364, 218-224.
Impact Factor: 5.4 -
Uehara, S. ; Shimizu, M. ; Plé, K. ; Routier, S. ; Yoneda, N. ; Higuchi, Y. ; Suemizu, H. ; Yamazaki, H.
Probe drug T-1032 N-oxygenation mediated by cytochrome P450 3A5 in human hepatocytes in vitro and in humanized-liver mice in vivo
Drug Metabolism and Pharmacokinetics 2022, 44, 100453.
Impact Factor: 2.1 -
Vercouillie, J. ; Buron, F. ; Sérrière, S. ; Rodrigues, N. ; Gulhan, Z. ; Chartier, A. ; Chicheri, G. ; Marzag, H. ; Oury, A. ; Percina, N. ; Bodard S. ; Ben Othman, R. ; Busson, J. ; Suzenet, F. ; Guilloteau, D. ; Marchivie, M. ; Emond, P. ; Routier, S. ; Chalon, S.
Development and preclinical evaluation of [18F]FBVM as a new potent PET tracer for vesicular acetylcholine transporter
Eur. J. Med. Chem. 2022, 244, 114794.
Impact Factor: 6.7 -
Buron, F. ; Rodrigues, N. ; Saurat, T. ; Hiebel, M.-A. ; Bourg, S. ; Bonnet, P. ; Nehmé, R. ; Morin, Ph. ; Percina, N. ; Corret, J. ; Vallée, B. ; Le Guével, R. ; Jourdan, M.-L. ; Bénédetti, H. ; Routier, S.
Design, Synthesis and SAR in 2,4,7-Trisubstituted Pyrido[3.2-d]Pyrimidine Series as Novel PI3K/mTOR Inhibitors
Molecules 2021, 26, 5349.
Impact Factor: 4.927 -
Chaney, A. M. ; Lopez-Picon, F. R. ; Sérrière, S. ; Wang, R. ; Bochicchio, D. ; Webb, S. D. ; Vandesquille, M. ; Harte, M. K. ; Georgiadou, C. ; Lawrence, C. ; Busson, J. ; Vercouillie, J. ; Tauber, C. ; Buron, F. ; Routier, S. ; Reekie, T. ; Snellman, A. ; Kassiou, M. ; Rokka, J. ; Davies, K. E. ; Rinne, J. O. ; Salih, D. A. ; Edwards, F. A. ; Orton, L. D. ; Williams, S. R. ; Chalon, S. ; Boutin, H.
Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study
Theranostics 2021, 11, 6644-6667.
Impact Factor: 11.556 -
Dagallier, C. ; Avry, F. ; Touchefeu, Y. ; Buron, F. ; Routier, S. ; Chérel, M. ; Arlicot, N.
Development of PET Radioligands Targeting COX-2 for Colorectal Cancer Staging, a Review of in vitro and Preclinical Imaging Studies
Frontiers in Medicine 2021, 8, 675209.
Impact Factor: 5.058 -
Laurent, M. ; Bostyn, S. ; Marchivie, M. ; Robin, Y. ; Routier, S. ; Buron, F.
Aminations and arylations by direct C–O activation for the design of 7,8-dihydro-6H-5,8-ethanopyrido[3,2-d]pyrimidines
RSC Advances 2021, 11, 19363-19377.
Impact Factor: 4.036 -
Sava, A. ; Buron, F. ; Routier, S. ; Panainte, A. ; Bibire, N. ; Profire, L.
New nitric oxide-releasing indomethacin derivatives with 1,3-thiazolidine-4-one scaffold: Design, synthesis, in silico and in vitro studies
Biomedicine & Pharmacotherapy 2021, 139, 111678.
Impact Factor: 7.419 -
Sava, A. ; Buron, F. ; Routier, S. ; Panainte, A. ; Bibire, N. ; Constantin, S. M. ; Lupascu, F. G. ; Fosca, A. V. ; Profire, L.
Design, synthesis, in silico and in vitro studies for new nitric oxide-releasing indomethacin derivatives with 1,3,4-oxadiazole-2-thiol scaffold
Int. J. Mol. Sci. 2021, 22, 7079.
Impact Factor: 6.208 -
Vasincu, I. M. ; Apotrosoasei, M. ; Constantin, S. ; Butnaru, M. ; Verestiuc, L. ; Lupușoru, C.-E. ; Buron, F. ; Routier, S. ; Lupașcu, D. ; Taușer, R.-G. ; Profire, L.
New ibuprofen derivatives with thiazolidine-4-one scaffold with improved pharmaco-toxicological profile
BMC Pharmacol. Toxicol. 2021, 22, 10.
Impact Factor: 2.605 -
Vetel, S. ; Foucault-Fruchard, L. ; Tronel, C. ; Buron, F. ; Vergote, J. ; Bodard S. ; Routier, S. ; Sérrière, S. ; Chalon, S.
Neuroprotective and anti-inflammatory effects of a therapy combining agonists of nicotinic α7 and σ1 receptors in a rat model of Parkinson’s disease
Neural Regeneration Research 2021, 16, 1099-1104.
Impact Factor: 6.058 -
Zak, A. ; Marzag, H. ; Rodrigues, N. ; Vercouillie, J. ; Chalon, S. ; Buron, F. ; Routier, S.
Synthesis of γ-carboline N-oxide under gold(I)-catalysis and C-1 amino and fluoro γ-carboline
Tetrahedron 2021, 89, 132154.
Impact Factor: 2.388 -
Zak, A. ; Lemaire, L. ; Chalon, S. ; Chicheri, G. ; Marzag, H. ; Bodard S. ; Serriere, S. ; Routier, S. ; Buron, F. ; Vercouillie, J.
[18F]-labeled positron emission tomography ligand for the histamine H4 receptor
J. Labelled Compd. Radiopharm. 2021, .
Impact Factor: 1.949 -
Constantin, S. M. ; Lupascu, F. G. ; Apotrosoasei, M. ; Fosca, A. V. ; Vasincu, I. M. ; Confederat, L. G. ; Dimitriu, G. ; Lupușoru, C.-E. ; Routier, S. ; Buron, F. ; Profire, L.
Antidiabetic effects and safety profile of chitosan delivery systems loaded with new xanthine-thiazolidine-4-one derivatives: in vivo studies
Journal of Drug Delivery Science and Technology 2020, 60, 102091.
Impact Factor: 3.981 -
Elie, J. ; Feizbakhsh, O. ; Desban, N. ; Josselin, B. ; Baratte, B. ; Bescond, A. ; Duez, J. ; Fant, X. ; Bach, S. ; Marie, D. ; Place, M. ; Ben Salah, S. ; Chartier, A. ; Berteina-Raboin, S. ; Chaikuad, A. ; Knapp, S. ; Carles, F. ; Bonnet, P. ; Buron, F. ; Routier, S. ; Ruchaud, S.
Design of new disubstituted imidazo[1,2-b]pyridazine derivatives as selective Haspin inhibitors. Synthesis, binding mode and anticancer biological evaluation
J. Enzym. Inhib. Med. Chem. 2020, 35, 1840–1853.
Impact Factor: 5.051 -
Focsa, A. ; Iacob, A. ; Vasincu, I. ; Constantin, S. ; Andriescu, L. ; Sava, A. ; Buron, F. ; Routier, S. ; Apotrosoasei, M. ; Profire, L.
Optimization of the synthesis of diclofenac derivatives with hydrazone structure and in vitro evaluation of the anti-inflammatory potential
Revista de Chimie (Bucharest) 2020, 71, 305-314.
Impact Factor: 1.755 -
Focsa, A. ; Iacob, A. ; Vasincu, I. ; Constantin, S. ; Andriescu, L. ; Sava, A. ; Buron, F. ; Routier, S. ; Profire, L.
The antioxidant potential evaluation of diclofenac derivatives with hydrazones structure
Farmacia 2020, 68, 329-334.
Impact Factor: 1.433 -
Soklou, K. E. ; Marzag, H. ; Bouillon, J.-P. ; Marchivie, M. ; Routier, S. ; Plé, K.
Gold(I)-catalyzed intramolecular hydroamination and hydroalkoxylation of alkynes: access to original heterospirocycles
Org. Lett. 2020, 22, 5973–5977.
Impact Factor: 6.005 -
Vetel, S. ; Vercouillie, J. ; Buron, F. ; Vergote, J. ; Tauber, C. ; Busson, J. ; Chicheri, G. ; Routier, S. ; Sérrière, S. ; Chalon, S.
Longitudinal PET imaging of α7 nicotinic acetylcholine receptors with [18F]ASEM in a Rat model of Parkinson’s disease
Molecular Imaging and Biology 2020, 22, 348-357.
Impact Factor: 3.488 -
Constantin, S. M. ; Buron, F. ; Routier, S. ; Vasincu, I. M. ; Apotrosoasei, M. ; Lupaşcu, F. ; Confederat, L. ; Tuchilus, C. ; Constantin, M. T. ; Sava, A. ; Profire, L.
Formulation and characterization of new polymeric systems based on chitosan and xanthine derivatives with thiazolidin-4-one scaffold
Materials 2019, 12, 558.
Impact Factor: 3.057 -
Elie, J. ; Vercouillie, J. ; Arlicot, N. ; Lemaire, L. ; Bidault, R. ; Bodard S. ; Hosselet, C. ; Deloye, J.-B. ; Chalon, S. ; Emond, P. ; Guilloteau, D. ; Buron, F. ; Routier, S.
Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [18F] PET tracer
J. Enzym. Inhib. Med. Chem. 2019, 34, 1-7.
Impact Factor: 4.673 -
Ouach, A. ; Vercouillie, J. ; Bertrand, E. ; Rodrigues, N. ; Pin, F. ; Serriere, S. ; Boiaryna, L. ; Chartier, A. ; Percina, N. ; Tangpong, P. ; Gulhan, Z. ; Mothes C. ; Deloye, J.-B. ; Guilloteau, D. ; Page, G. ; Suzenet, F. ; Buron, F. ; Chalon, S. ; Routier, S.
Bis(het)aryl-1,2,3-triazole quinuclidines as α7 nicotinic acetylcholine receptor ligands: Synthesis, structure affinity relationships, agonism activity, [18F]-radiolabeling and PET study in rats
Eur. J. Med. Chem. 2019, 179, 449-469.
Impact Factor: 5.572 -
Oukoloff, K. ; Coquelle, N. ; Bartolini, M. ; Naldi, M. ; Le Guével, R. ; Bach, S. ; Josselin, B. ; Ruchaud, S. ; Catto, M. ; Pisani, L. ; Denora, N. ; Iacobazzi, R. M. ; Silman, I. ; Sussman, J. L. ; Buron, F. ; Colletier, J.-P. ; Jean, L. ; Routier, S. ; Renard, P.-Y.
Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3
Eur. J. Med. Chem. 2019, 168, 58-77.
Impact Factor: 5.572
the average impact factor is : 4.591
Refereed articles (rank B)
-
Sava, A. ; Panainte, A. ; Bibire, N. ; Constantin, S. ; Fosca, A. V. ; Buron, F. ; Routier, S. ; Profire, L.
A rapid, simple and sensitive spectrophotometric method for the determination of no from no donors
Pharmacy 2020, 124, 678-684.
Conference proceedings
-
Caré, F. ; Sangare, D. ; Bostyn, S. ; Routier, S. ; Lafite, P. ; Buron, F.
Innovative processes for natural active ingredients extraction and their online functionalization using flow chemistry technology
Int. J. Cosmet. Sci. 2023, 45, 53. -
Serrano, A. ; Ribes, J. ; Daligaux, P. ; Chesné, C. ; Plé, K. ; Routier, S. ; Vallée, B. ; Bénédetti, H.
Protein extinction by protacs to evaluate the safety of cosmetic compounds
Int. J. Cosmet. Sci. 2023, 45, 29.